【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 14
2 Introduction 15
2.1 Ovarian Cancer Overview 15
3 Products under Development 16
3.1 Ovarian Cancer – Pipeline Products by Stage of Development 16
3.2 Ovarian Cancer – Pipeline Products by Territory 17
3.3 Ovarian Cancer – Pipeline Products by Regulatory Path 18
3.4 Ovarian Cancer – Pipeline Products by Estimated Approval Date 19
3.5 Ovarian Cancer – Ongoing Clinical Trials 20
4 Ovarian Cancer – Pipeline Products under Development by Companies 21
4.1 Ovarian Cancer Companies – Pipeline Products by Stage of Development 21
4.2 Ovarian Cancer – Pipeline Products by Stage of Development 25
5 Ovarian Cancer Companies and Product Overview 29
5.1 A&G Pharmaceutical, Inc. Company Overview 29
5.1.1 A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Abcodia Ltd. Company Overview 31
5.2.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
5.3 Abnova Corporation Company Overview 32
5.3.1 Abnova Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Adaptive Biotechnologies Corporation Company Overview 34
5.4.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
5.5 Almac Diagnostics Limited Company Overview 35
5.5.1 Almac Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 AroCell AB Company Overview 36
5.6.1 AroCell AB Pipeline Products & Ongoing Clinical Trials Overview 36
5.7 Arrayit Diagnostics, Inc. Company Overview 37
5.7.1 Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 ArtemixRx Company Overview 39
5.8.1 ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Aurelium BioPharma Inc. (Inactive) Company Overview 40
5.9.1 Aurelium BioPharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 Axela Inc. Company Overview 42
5.10.1 Axela Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Ayanda Biosystems S.A. Company Overview 43
5.11.1 Ayanda Biosystems S.A. Pipeline Products & Ongoing Clinical Trials Overview 43
5.12 Becton, Dickinson and Company Company Overview 44
5.12.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 44
5.13 Bioindustry Park Silvano Fumero S.p.A. Company Overview 46
5.13.1 Bioindustry Park Silvano Fumero S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 46
5.14 BioMark Diagnostics Inc. Company Overview 47
5.14.1 BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.15 Ceres Nanosciences, Inc. Company Overview 48
5.15.1 Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.16 Chronix Biomedical, Inc. Company Overview 50
5.16.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.17 Clarient, Inc. Company Overview 52
5.17.1 Clarient, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.18 ClavGen Therapeutics LLC Company Overview 53
5.18.1 ClavGen Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 53
5.19 Cleveland Diagnostics Inc. Company Overview 54
5.19.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.20 Clovis Oncology, Inc. Company Overview 55
5.20.1 Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.21 Cornell University Company Overview 57
5.21.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 57
5.22 Courtagen Life Sciences, Inc. Company Overview 58
5.22.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.23 CS-Keys, Inc. Company Overview 59
5.23.1 CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.24 Dako A/S Company Overview 60
5.24.1 Dako A/S Pipeline Products & Ongoing Clinical Trials Overview 60
5.25 Dana-Farber Cancer Institute, Inc. Company Overview 61
5.25.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.26 diaDexus, Inc. Company Overview 62
5.26.1 diaDexus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.27 Eventus Diagnostics, Inc. Company Overview 67
5.27.1 Eventus Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.28 Exiqon A/S Company Overview 68
5.28.1 Exiqon A/S Pipeline Products & Ongoing Clinical Trials Overview 68
5.29 Exosomics Siena SpA Company Overview 70
5.29.1 Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 70
5.30 Foundation Medicine, Inc. Company Overview 71
5.30.1 Foundation Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.31 Ganymed Pharmaceuticals AG Company Overview 73
5.31.1 Ganymed Pharmaceuticals AG Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 GeneNews Limited Company Overview 74
5.32.1 GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 Georgia Institute of Technology Company Overview 76
5.33.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 76
5.34 GlycoZym Company Overview 78
5.34.1 GlycoZym Pipeline Products & Ongoing Clinical Trials Overview 78
5.35 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 79
5.35.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.36 Ikonisys, Inc. Company Overview 80
5.36.1 Ikonisys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.37 Inanovate (UK) Ltd. Company Overview 81
5.37.1 Inanovate (UK) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 81
5.38 IncellDx, Inc. Company Overview 82
5.38.1 IncellDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.39 Innovative Health Diagnostics Company Overview 83
5.39.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 83
5.40 Institut National de la Sante et de la Recherche Medicale Company Overview 84
5.40.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 84
5.41 InterGenetics Incorporated Company Overview 85
5.41.1 InterGenetics Incorporated Pipeline Products & Ongoing Clinical Trials Overview 85
5.42 IV Diagnostics, Inc. Company Overview 86
5.42.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.43 KIYATEC Inc. Company Overview 87
5.43.1 KIYATEC Inc. Pipeline Products & Ongoing Clinical Trials Overview 87
5.44 Lab Discoveries Ltd. Company Overview 88
5.44.1 Lab Discoveries Ltd. Pipeline Products & Ongoing Clinical Trials Overview 88
5.45 Laboratorios SALVAT S.A. Company Overview 89
5.45.1 Laboratorios SALVAT S.A. Pipeline Products & Ongoing Clinical Trials Overview 89
5.46 Laboratory Corporation of America Holdings Company Overview 90
5.46.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 90
5.47 Louisville Bioscience, Inc. Company Overview 92
5.47.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 92
5.48 MabCure Inc. Company Overview 93
5.48.1 MabCure Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.49 Manalto Limited Company Overview 95
5.49.1 Manalto Limited Pipeline Products & Ongoing Clinical Trials Overview 95
5.50 MDNA Life Sciences, Inc. Company Overview 100
5.50.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100
5.51 MDxHealth SA Company Overview 101
5.51.1 MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview 101
5.52 Metabolon, Inc. Company Overview 103
5.52.1 Metabolon, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.53 Milagen, Inc. Company Overview 104
5.53.1 Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 104
5.54 Myriad Genetics, Inc. Company Overview 105
5.54.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.55 Nanosphere, Inc. Company Overview 107
5.55.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.56 National University of Singapore Company Overview 109
5.56.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 109
5.57 Neogenix Oncology, Inc. Company Overview 110
5.57.1 Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.58 Novel Bio-spectrum Technologies, Inc. Company Overview 111
5.58.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.59 NuCana BioMed Limited Company Overview 112
5.59.1 NuCana BioMed Limited Pipeline Products & Ongoing Clinical Trials Overview 112
5.60 Oncgnostics GmbH Company Overview 113
5.60.1 Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 113
5.61 Orion Genomics LLC Company Overview 114
5.61.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 114
5.62 Oryzon Genomics S.A. Company Overview 115
5.62.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 115
5.63 OTraces Inc. Company Overview 116
5.63.1 OTraces Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.64 OvaGene Oncology Inc. Company Overview 117
5.64.1 OvaGene Oncology Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.65 PeriRx LLC Company Overview 118
5.65.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 118
5.66 Pronota NV Company Overview 119
5.66.1 Pronota NV Pipeline Products & Ongoing Clinical Trials Overview 119
5.67 Protagen AG Company Overview 120
5.67.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 120
5.68 Proteomika Company Overview 121
5.68.1 Proteomika Pipeline Products & Ongoing Clinical Trials Overview 121
5.69 Provista Diagnostics Inc. Company Overview 122
5.69.1 Provista Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 122
5.70 RCP Diagnostics, LLC (Inactive) Company Overview 123
5.70.1 RCP Diagnostics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 123
5.71 RiboMed Biotechnologies, Inc. Company Overview 124
5.71.1 RiboMed Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.72 Rice University Company Overview 125
5.72.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 125
5.73 Roche Diagnostics International Ltd. Company Overview 127
5.73.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 127
5.74 Rosetta Genomics, Ltd. Company Overview 129
5.74.1 Rosetta Genomics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 129
5.75 Rush University Medical Center Company Overview 131
5.75.1 Rush University Medical Center Pipeline Products & Ongoing Clinical Trials Overview 131
5.76 SomaLogic, Inc. Company Overview 132
5.76.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 132
5.77 Soricimed Biopharma Inc. Company Overview 133
5.77.1 Soricimed Biopharma Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.78 Stage I Diagnostics, Inc. Company Overview 135
5.78.1 Stage I Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.79 SurExam Life Science & Technology Co. Company Overview 136
5.79.1 SurExam Life Science & Technology Co. Pipeline Products & Ongoing Clinical Trials Overview 136
5.80 Target Discovery, Inc. Company Overview 137
5.80.1 Target Discovery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.81 Teva Pharmaceutical Industries Limited Company Overview 138
5.81.1 Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview 138
5.82 The Johns Hopkins University Company Overview 140
5.82.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 140
5.83 The University of Adelaide Company Overview 142
5.83.1 The University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview 142
5.84 The University of Texas M. D. Anderson Cancer Center Company Overview 143
5.84.1 The University of Texas M. D. Anderson Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 143
5.85 Todos Medical Company Overview 144
5.85.1 Todos Medical Pipeline Products & Ongoing Clinical Trials Overview 144
5.86 Transbiomed, SL Company Overview 145
5.86.1 Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview 145
5.87 Universite de Montreal Company Overview 146
5.87.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 146
5.88 University of South Florida Company Overview 148
5.88.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 148
5.89 US Biomarkers, Inc. Company Overview 150
5.89.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.90 Vermillion, Inc. Company Overview 151
5.90.1 Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.91 Vitatex Inc. Company Overview 154
5.91.1 Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview 154
5.92 Vitruvian Biomedical, Inc. Company Overview 157
5.92.1 Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 157
5.93 Yale University Company Overview 158
5.93.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 158
6 Ovarian Cancer- Recent Developments 159
7 Appendix 171
7.1 Methodology 171
7.2 About GlobalData 173
7.3 Contact Us 174
7.4 Disclaimer 174
【レポート販売概要】
■ タイトル:世界における卵巣がん検査製品のパイプライン動向2015■ 英文:Ovarian Cancer - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0074EPD
■ 調査対象地域:グローバル
- ポリエーテルポリオールの世界市場The polyether polyols market was valued at estimated to be $12,374.9 million in 2012, and is projected to grow at a CAGR of 7.2% from 2014 to 2020. This market is also classified based on different applications. The important applications include Flexible Foam, Rigid Foam, and others (Adhesives, Sealents & Elastomers). The flexible foam is the largest reveue generator industry/segment in this mark …
- フェノール樹脂の世界市場 :レゾール型フェノール樹脂、ノボラック型フェノール樹脂About Phenolic Resins Phenolic resins are synthetic polymers formed by the reaction of phenol and formaldehyde. Phenolic resins have unique physical and chemical properties including high mechanical strength, temperature stability, flame resistance, water and chemical stability, low toxicity, and an excellent performance profile. Owing to their unique properties phenolic resins are used in a wide …
- ハロゲン市場:韓国This report is a comprehensive research of halogens market in South Korea. The report starts with giving brief country profile for South Korea, including general information and main economic indicators. Further, the report provides in-depth analyses halogens market in the country. It identifies key market players, including major producers, wholesalers and distributing companies. The third chapte …
- 自動車用排ガス熱回収(EGHR)システムの世界市場2018-2022About automotive exhaust gas heat recovery system (EGHR) An automotive exhaust gas heat recovery system (EGHR) is located in the exhaust system of the vehicle. This compact unit recovers heat from the vehicle exhaust and utilizes the heat to warm the engine fuels and the cabin. Technavio’s analysts forecast the Global automotive exhaust gas heat recovery system (EGHR) market to grow at a CAGR of 4 …
- 麻痺(Paralysis):グローバル臨床試験レビュー(2014年上半期)Paralysis Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Paralysis Global Clinical Trials Review, H1, 2014" provides data on the Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Paralysis. It includes an overview of the trial numbers and their recruitment status as per the site of trial c …
- ラジオサービスの世界市場:放送ラジオ、衛星ラジオ、オンライン/モバイルラジオAbout Radio Radio is a part of the electromagnetic spectrum and radio frequencies occupy the range from 3 kHz to 300 GHz of the spectrum. The radio waves travel through the atmosphere with various frequencies. The lower the frequency, the farther they travel. As the frequency increases, the waves might be interfered by external disturbances. The process of using radio waves to transmit data for co …
- 通信キャリアのコンテンツデリバリネットワーク(CDN)戦略This report explores telecom carriers’ strategies with respect to content delivery networks (CDN). It analyses the impact of telcos’ arrival into the CDN value chain, especially with respect to pure-player CDN companies and equipment suppliers. It concludes with an analysis of the market that telcos can expect to capture over the long term, especially in the realm of mobile solutions which today a …
- CMS Energy Corporation:発電所及び企業SWTO分析2015CMS Energy Corporation - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized …
- 神経学的バイオマーカーの世界市場2016-2020About Biomarkers Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are called neurological biomarkers. Technavio’s analysts forecast th …
- 透明エレクトロニクスの世界市場:用途別(タッチディスプレイ、光学的被覆、太陽光電池)、最終用途別(運輸、民生機器、エネルギーソース、その他)、地域別予測Global Transparent Electronics Market to reach USD xxx million by 2025. Global Transparent Electronics Market valued approximately USD xxx million in 2016 is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2017-2025 Silicon compounds are expected to have a major impact and can become a driving factor for the transparent electronic materials market. Transpar …
- 鉛蓄電池の世界市場予測(~2024年)“The global lead acid battery market is projected to grow at a CAGR of about 4 - 5% from 2019 to 2024” The global lead acid battery market is projected to reach USD 52.5 billion by 2024 from an estimated USD 41.6 billion in 2019, at a CAGR of 4.7% during the forecast period. This growth can be attributed to factors such as the basic requirement of cost-effective battery storage solutions in the de …
- 世界の無線ネットワークセキュリティ市場動向(2014-2019)Today, enterprises are relying more and more on wireless networks. There is no doubt that the wireless networking infrastructure has helped organizations to cut maintenance costs and increase the operating income. Although it looks good from the point of view of profitability, it also makes these organizations an easy target of cyber criminals. Wireless networks no doubt have their perks, but they …
- 世界主要国のD-ダイマー 検査(医療機器)市場The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and D-Dimer testing specifically, will become more standardized, offering opp …
- データセンタースイッチの世界市場:ポート速度別(10G以下、10G~25G、25G~40G、40G~100G、100G以上)、技術別(イーサネット、インフィニバンド、その他)、スイッチタイプ別(コア、ToRスイッチ、その他)、産業別(IT&テレコム、政府&防衛、金融、小売、製造、メディア&エンターテイメント、その他)A data center is a premise of networked computers and storage that organizations from various fields use to organize, process, store, and disseminate massive amounts of data. A business usually depends heavily on the applications, services, and data contained within a data center, making it the point of focus and a vital asset for day-to-day activities. The data center switch is usually found in t …
- 農薬と殺虫剤市場:タンザニアThis report is a comprehensive research of agrochemicals and pesticides market in Tanzania. The report starts with giving brief country profile for Tanzania, including general information and main economic indicators. Further, the report provides in-depth analyses agrochemicals and pesticides market in the country. It identifies key market players, including major producers, wholesalers and distri …